News from Novo Nordisk Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Dec 19, 2016, 14:00 ET Novo Nordisk Receives FDA Approval of Tresiba® (insulin degludec injection 100 U/mL, 200 U/mL) for Use in Children and Adolescents With Diabetes

Novo Nordisk, a world leader in diabetes care, today announced that the U.S. Food and Drug Administration (FDA) approved an expanded indication for...


Dec 07, 2016, 09:36 ET Novo Nordisk recognized for diversity and inclusion

Novo Nordisk in the United States is honored to have been recognized for demonstrating a strategic and long-term commitment to fostering diversity...


Dec 05, 2016, 09:42 ET Novo Nordisk Files for Regulatory Approval of Once-Weekly Semaglutide with the FDA for the Treatment of Type 2 Diabetes

Novo Nordisk today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for semaglutide, a...


Nov 21, 2016, 19:51 ET Novo Nordisk Receives FDA Approval for Xultophy® 100/3.6 (insulin degludec and liraglutide injection)

Novo Nordisk, a world leader in diabetes care, today announced that the U.S. Food and Drug Administration (FDA) approved the New Drug Application...


Nov 14, 2016, 08:05 ET One World Trade Center to Glow Blue in Honor of World Diabetes Day Tonight

Tonight, on World Diabetes Day, the spire of One World Trade Center will be lit in blue, the official color of diabetes, to raise awareness of the...


Nov 14, 2016, 02:00 ET Novo Nordisk Expands Programme to Reach 20,000 Children with Diabetes in Developing Countries

Today, Novo Nordisk announced a four-year extension of its Changing Diabetes® in Children programme which provides access to diabetes care and...


Nov 14, 2016, 02:00 ET Novo Nordisk amplía su programa humanitario para llegar a 20.000 niños con diabetes en los países en desarrollo

Novo Nordisk ha anunciado una ampliación de cuatro años en su programa Changing Diabetes® in Children que proporciona acceso al cuidado de la...


Nov 14, 2016, 02:00 ET Novo Nordisk erweitert sein Hilfsprogramm auf 20.000 Kinder mit Diabetes in Entwicklungsländern

Novo Nordisk gab heute eine Verlängerung seines Engagements "Changing Diabetes® in Children" um vier Jahre bekannt. Das Hilfsprogramm bietet...


Nov 14, 2016, 02:00 ET Novo Nordisk amplía su programa para cubrir a 20 mil niños con diabetes en los países en desarrollo

Novo Nordisk anunció hoy una extensión de cuatro años de su programa para cambiar la diabetes en los niños "Changing Diabetes® in...


Nov 14, 2016, 02:00 ET Novo Nordisk prolonge son programme afin de prendre en charge jusqu'à 20 000 enfants atteints de diabète dans les pays en voie de développement

Aujourd'hui, Novo Nordisk a annoncé une prolongation de quatre ans de son programme intitulé Changing Diabetes® in Children. Spécialement conçu...


Nov 14, 2016, 02:00 ET Novo Nordisk expande programa para alcançar 20.000 crianças com diabetes em países em desenvolvimento

A Novo Nordisk acaba de anunciar uma extensão de quatro anos em seu programa Changing Diabetes® in Children (Mudando o Diabetes em Crianças,...


Nov 14, 2016, 02:00 ET Novo Nordisk forlænger og udvider program for børn med type 1-diabetes i udviklingslande

Novo Nordisk har besluttet at forlænge sit Changing Diabetes® in Children-program med fire år - et program, som giver børn med type 1-diabetes i...


Nov 01, 2016, 04:00 ET New Data Show Post-Meal Hyperglycaemia is Associated with a Negative Impact on Quality of Life for People with Diabetes

This material is intended for global medical media only. For journalistic assessment and preparation before publication. Abstract: 69477 New...


Oct 27, 2016, 09:00 ET Novo Nordisk to present eight abstracts at the 4th annual ObesityWeek in New Orleans, LA

Novo Nordisk, a global leader in obesity care, today announced that data from eight abstracts, including six posters and two oral presentations,...


Sep 27, 2016, 12:48 ET Working Mother names Novo Nordisk Inc. one of its "100 Best Companies"

 Working Mother magazine today recognized Novo Nordisk Inc. as one of the 2016 "Working Mother 100 Best Companies." Novo Nordisk, a world...


Sep 16, 2016, 02:31 ET Semaglutide reduced major cardiovascular events by 26% in adults with type 2 diabetes at high cardiovascular risk

This material is intended for global medical media only.   For journalistic assessment and preparation before...


Sep 15, 2016, 12:37 ET Great Place to Work® and Fortune name Novo Nordisk as one of the country's best workplaces for women

Novo Nordisk is one of the 2016 Best Workplaces for Women, according to global research and consulting firm Great Place to Work® and...


Sep 08, 2016, 14:16 ET Novo Nordisk Inc. issues voluntary nationwide recall of six batches of GlucaGen® HypoKit® (glucagon [rDNA origin] for injection) due to detached needles on the syringe in the kit

 Novo Nordisk Inc. is recalling six batches of the GlucaGen® HypoKit® in the U.S. due to two customer complaints from the UK and...


Aug 15, 2016, 08:30 ET Hip-Hop Legend Rev Run and Wife Justine Simmons Unveil Experiential Photo Exhibit with Novo Nordisk Depicting the Millions of Americans at Risk of Diabetes

 Novo Nordisk today unveiled the "Am I at Risk?" traveling exhibit as an extension of its Ask.Screen.Know.® program urging adults to know...


Jul 26, 2016, 09:00 ET Novo Nordisk announces new data on psychosocial impact of people living with hemophilia B

Novo Nordisk today announced the first results from the Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S)...


Jul 11, 2016, 12:00 ET Novo Nordisk to Present 28 Abstracts at the World Federation of Hemophilia World Congress in Orlando

Novo Nordisk announced today that data from 28 abstracts will be shared at the upcoming World Federation of Hemophilia (WFH) World Congress in...


Jul 06, 2016, 09:00 ET Unique New Book Series from Novo Nordisk and JDRF Uses Customized Information by Age to Educate Children and Young Adults with Type 1 Diabetes

 Novo Nordisk, the global diabetes leader and JDRF, the leading research and advocacy organization funding type 1 diabetes (T1D) research,...


Jun 29, 2016, 09:00 ET Novo Nordisk Inc. Partners with Tony Award®-Winning Actor and Entertainer Ben Vereen and Academy of Country Music Nominee RaeLynn

Novo Nordisk, a world leader in diabetes care, today announced new partnerships with Tony Award®-winning actor and entertainer Ben Vereen and...


Jun 16, 2016, 12:00 ET New research identifies Houston's vulnerability to diabetes; highlights public health crisis

 Research sponsored by Novo Nordisk and conducted in collaboration with the University of Texas Health Science Center at Houston (UTHealth)...


Jun 13, 2016, 17:15 ET Victoza® (liraglutide) significantly reduced the risk of major cardiovascular events and death in adults with type 2 diabetes in the LEADER trial

Novo Nordisk today announced that Victoza® (liraglutide) injection 1.2 mg or 1.8 mg significantly reduced the risk of the composite primary...